Sensex plunges 156 pts; caution prevails ahead of US election

Image
Press Trust of India Mumbai
Last Updated : Nov 04 2016 | 5:58 PM IST
Spooked investors remained hesitant for the fifth session in a row amid uncertainty over US election result, pulling Sensex 156 points to near four-month low of 27,274.15 led by huge sell-off in pharma counters.
For the week, the first of the new Samvat Year 2073, the Sensex and Nifty both recorded losses by plunging 667.36 points, or 2.38 per cent, and 204.25 points, or 0.36 per cent, respectively.
The relentless losses in stocks continued amid sustained selling by foreign funds and retail investors, tracking global cues dominated by fear that market favourite Hillary Clinton is lagging behind Donald Trump in the US presidential race.
Investors could not find any solace even after the finalisation of tax structure by the GST council as markets continued to ferry in the negative zone.
Moreover, domestic market woes piled up as the session saw pharma stocks tumbling following reports of a likely US probe against Indian pharma companies making generic drugs.
Reacting to the news, Sunpharma shares tumbled 7.45 per cent, followed by Dr Reddy 5.67 per cent, Lupin 3.57 per cent and Cipla 2.60 per cent.
Vinod Nair, Head of Research, Geojit BNP Paribas Financial Services Ltd, said, "Market tumbled as investors are concerned over the final lap of US political battle and higher tax burden from GST. Even though GST is one step closer, white goods were impacted on fears of a higher tax burden than expected earlier. Pharma companies are the major casualty due to the price collusion in US market. The rising volatility led the investors to wait and watch for a favorable risk reward."
The Sensex, which had lost 511.23 points in the previous four sessions, dropped by another 156.13 points, or 0.57 per cent, to end at 27,274.15, its lowest closing since July 8. It shuttled between 27,498.91 and 27,193.61. The 30-share index hit the day's lowest at 27,193.61.
The NSE Nifty shed 51.20 points, or 0.60 per cent, to end at 8,433.75, after moving between 8,504 and 8,400.25.
The broader markets too remained under pressure as investors indulged in cutting down their bets with the small-cap index falling by 2.20 per cent and the mid-cap index shedding 1.34 per cent.
Bucking the overall trend, shares of consumer goods companies turned buyers' fancy on hopes that lower tax rates would be applied after a four-tier GST tax structure of 5, 12, 18 and 28 per cent decided by a high-powered council yesterday.
Foreign portfolio investors (FPIs) sold shares worth a net Rs 706.77 crore yesterday, as per provisional data.
Globally, in the Asian region, Japan's Nikkei fell 1.34 per cent, Shanghai Composite fell 0.12 per cent, while Hong Kong's Hang Seng down 0.18 per cent.
(Reopen DEL44)
Moving to the domestic market, 18 scrips ended lower while 12 others closed higher.
Besides pharma majors, other major laggards were Coal India 3.44 per cent, Hero Motocorp 2.86 per cent, RIL 1.92 per cent, L&T 1.78 per cent, Maruti 1.58 per cent, HDFC 1.41 per cent and SBI 1.14 per cent.
While, shares of cigarette major ITC jumped 3.64 per cent to Rs 249.05 after fears of GST overhang subsided after the finalisation of a four-tier tax structure. Earlier, there were uncertainties about charging higher tax on tobacco post GST.
Other gainers were M&M 1.02 per cent, HUL 0.91 per cent, Wipro 0.91 per cent, ONGC 0.78 per cent and Asian Paints 0.55 per cent.
Among the sectoral indices, healthcare dropped 4.16 per cent, realty 2.44 per cent, metal 2.41 per cent, telecom 2.08 per cent, capital goods 1.72 per cent, consumer durables 1.60 per cent and energy 1.35 per cent.
However, FMCG rose by 1.41 per cent and IT 0.66 per cent.
The market breadth remained negative as 2,224 stocks ended in red, 681 closed in red while 115 ruled steady.
Total turnover on BSE amounted to Rs 4,542.79 crore, higher than turnover of Rs 3,202.47 crore registered during the previous trading session.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 04 2016 | 5:58 PM IST

Next Story